Nomura Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Nomura Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,180	Closed	-$584K	–	954
2017 Q3	$584K	Buy	5,180 +3,450	+199%	+$375K	0.01%	798
2017 Q2	$194K	Hold	1,730	–	–	﹤0.01%	893
2017 Q1	$202K	Hold	1,730	–	–	﹤0.01%	902
2016 Q4	$182K	Sell	1,730 -10,600	-86%	-$1.11M	﹤0.01%	921
2016 Q3	$1.36M	Buy	12,330 +1,650	+15%	+$218K	0.02%	539
2016 Q2	$1.55M	Buy	+10,680	New	+$1.51M	0.03%	475

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Nomura Asset Management's TARO Position: Q4 2017 in Review

Nomura Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 5,180 shares — an estimated $584K sold.

Nomura Asset Management first reported a position in TARO in Q2 2016 and held it in 6 quarters. The position peaked at $1.55M in Q2 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

Nomura Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
Nomura Asset Management sold 5,180 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $584K.
Nomura Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and held it in 6 quarters.
Nomura Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $1.55M in Q2 2016.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Nomura Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.